This CX Programme is subject to change.

Peripheral Arterial Podium 1st Session - Thursday, 23rd April
Venue:   Lower Main Auditorium
Podium 1st: Absence of long-term benefit revascularisation in claudicants - five-year results from the IRONIC randomised trial
Speaker:   Joakim Nordanstig, Molndal, Sweden
Audience participation and discussion
Podium 1st: Mid-term follow-up, safety and efficacy of patients treated with a rotational atherectomy device
Speaker:   Sorin Giusca, Weinheim, Germany
Audience participation and discussion
Podium 1st: Value of a new balloon-expandable stent graft in treating challenging aortoiliac occlusive lesions - three-year results, advantages and limitations
Speaker:   Andrew Holden, Auckland, New Zealand
Audience participation and discussion
Podium 1st: IN.PACT Global Study four-year outcomes - stented vs. non-stented subset
Speaker:   Gary Ansel, Columbus, United States
Audience participation and discussion
Podium 1st: ZILVERPASS 24-month results
Speaker:   Marc Bosiers, Dendermonde, Belgium
Audience participation and discussion
Podium 1st: MIMICS-2 study three-year results
Speaker:   Thomas Zeller, Bad Krozingen, Germany
Audience participation and discussion
Podium 1st : IN.PACT BTK European study - first presentation of the nine-month primary outcomes
Speaker:   Antonio Micari, Palermo, Italy
Audience participation and discussion
Podium 1st: Drug-eluting stent global data analysis - which patients get better and which do not
Speaker:   Gary Ansel, Columbus, United States
Audience participation and discussion
Audience participation and discussion
Podium 1st: New data release, safety and efficacy data from the ILLUMENATE Global single-arm study
Speaker:   TBA
Audience participation and discussion